awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35078290-31E143AD-FE25-4475-AECA-19DA6A8D6D20
Q35078290-31E143AD-FE25-4475-AECA-19DA6A8D6D20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35078290-31E143AD-FE25-4475-AECA-19DA6A8D6D20
A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin
P2860
Q35078290-31E143AD-FE25-4475-AECA-19DA6A8D6D20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35078290-31E143AD-FE25-4475-AECA-19DA6A8D6D20
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b4fd389aef7ed3d0d797a234c42f3fb10a0abde0
P2860
HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression.